Please assess the completion status of the following clinical trial:

Trial Title: Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy with no chronic illness~* Age 18-35~* Normal BMI (18-25)~* Normal screening labs or no clinically significant values~Exclusion Criteria:~* First degree relative with Type 2 Diabetes~* Smoking presently or in the past 6 months~* Medications that affect the vasculature~* Overweight or other indications of insulin resistance~* Elevated LDL cholesterol \> 160~* Elevated BP \> 140/90~* History of congestive heart failure, ischemic heart disease, severe pulmonary disease, liver or kidney disease, bleeding disorders~* Any vascular disease such as myocardial infarction, stroke, peripheral vascular disease~* Presence of an intracardiac or intrapulmonary shunt (we will screen for this by auscultation during the physical exam by PI).~* Pregnant or breastfeeding.~* Known hypersensitivity to perflutren (contained in Definity)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Octreotide- Euglycemia (Type: ACTIVE_COMPARATOR): octreotide is 30 ng/kg/min x 240 min insulin 0.15mU/kg/min x 240 min Dextrose 20% at variable rate to maintain euglycemia for 240 min
- Octreotide - Euglycemia- insulin clamp (Type: ACTIVE_COMPARATOR): octreotide is 30 ng/kg/min x 330 min insulin 0.15mU/kg/min x 210 min insulin 1.0mU/kg/min x 120 min Dextrose 20% at variable rate to maintain euglycemia for 330 min
- Octreotide- hyperglycemia (Type: ACTIVE_COMPARATOR): octreotide is 30 ng/kg/min x 330 min insulin 0.15mU/kg/min x 330 min Dextrose 20% at variable rate to maintain euglycemia for 90 min Dextrose 20% at variable rate to maintain hyperglycemia for 240 min
- Octreotide- hyperglycemia - insulin clamp (Type: ACTIVE_COMPARATOR): octreotide is 30 ng/kg/min x 330 min insulin 0.15mU/kg/min x 210 min insulin 1.0mU/kg/min x 120 min Dextrose 20% at variable rate to maintain euglycemia for 90 min Dextrose 20% at variable rate to maintain hyperglycemia for 240 min

Based on this trial design, predict the completion outcome and termination type (if applicable).